Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

Momentum Data

Status: Completed

Conditions: Atopic Dermatitis; Atopic Dermatitis Eczema; Eczema

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT03823794

P002

Details and patient eligibility

About

Atopic dermatitis (AD), commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used.

Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently.

Full description

Objective

The study aims to describe the health care resource utilisation of patients with active AD in terms of prescription use, primary care appointments, and specialist referrals.

Method This study will define AD cases using a previously validated algorithm for case identification use clinical codes form primary care in the UK (Read codes). The study will analyse a cohort of prevalent active AD cases over a one year period (2018). The annual use of topical and oral medications used for the treatment of AD, primary care appointments, and specialist referrals will be reported.

Enrollment: 148,166 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All paediatric and adult patients registered with an Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) contributing GP practice during the study period (2008-2018) and with at least one year of follow-up.

Exclusion criteria

• The presence of psoriasis, photodermatitis, or ichthyosis

Trial design

148,166 participants in 1 patient group

Active atopic dermatitis

Description:

People fulfilling the diagnostic criteria for active atopic dermatitis during the calendar year 2018, and meeting the inclusion criteria and registered with one of the study practices for one or more years during the study period.

Treatment:

Other: No intervention